Can serum interleukin-2 receptor alpha predict lymph node metastasis in early gastric cancer?

Journal of the Korean Surgical Society

Volumn 82, Issue 3, 2012, Pages 143-148

  Baik, Yong Hae ^a   An, Ji Yeong ^b   Noh, Jae Hyung ^c   Sohn, Tae Sung ^c   Kim, Sung ^c  

^a Dongguk University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Lymphatic metastasis; Prediction; Serum marker; Stomach neoplasms

Indexed keywords

EID: 84860425968     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2012.82.3.143     Document Type: Article

References (20)

1. Kim MG, Kim BS, Kim TH, Kim KC, Yook JH, Oh ST, et al. Surgical treatment for patients who underwent endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD) of early gastric cancer (EGC). J Korean Surg Soc 2011;80:165-71.
2. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994;4:146-8. (Pubitemid 24105436)
3. Heo GU, Kim MC, Jung GJ, Choi SR. Robotic gastrectomy for gastric cancer: preliminary results. J Korean Surg Soc 2009;76:301-6.
4. Lee JH, Kim JJ. Endoscopic mucosal resection of early gastric cancer: Experiences in Korea. World J Gastroenterol 2007;13:3657-61. (Pubitemid 47202161)
5. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Farinati F, et al. Lymphadenectomy in patients with gastric cancer. A critical review. Suppl Tumori 2003;2:S35-8.
6. Yanai H, Noguchi T, Mizumachi S, Tokiyama H, Nakamura H, Tada M, et al. A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. Gut 1999;44:361-5. (Pubitemid 29119331)
7. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988;240:1169-76.
8. Saito H, Tsujitani S, Katano K, Ikeguchi M, Maeta M, Kaibara N. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer. Surg Today 1998;28:1115-7. (Pubitemid 28482079)
9. Fukuya T, Honda H, Hayashi T, Kaneko K, Tateshi Y, Ro T, et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 1995;197:705-11.
10. Dehn TC, Reznek RH, Nockler IB, White FE. The pre-operative assessment of advanced gastric cancer by computed tomography. Br J Surg 1984;71:413-7. (Pubitemid 14116559)
11. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991;180:319-22.
12. Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy 1993;25:162-6. (Pubitemid 23107977)
13. Maehara Y, Okuyama T, Oshiro T, Baba H, Anai H, Akazawa K, et al. Early carcinoma of the stomach. Surg Gynecol Obstet 1993;177:593-7.
14. Tsujitani S, Oka S, Saito H, Kondo A, Ikeguchi M, Maeta M, et al. Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery 1999;125:148-54. (Pubitemid 29076108)
15. Abe N, Watanabe T, Suzuki K, Machida H, Toda H, Nakaya Y, et al. Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg 2002;183:168-72. (Pubitemid 34246430)
16. Wu CY, Chen JT, Chen GH, Yeh HZ. Lymph node metastasis in early gastric cancer: a clinicopathological analysis. Hepatogastroenterology 2002;49:1465-8.
17. Folli S, Morgagni P, Roviello F, De Manzoni G, Marrelli D, Saragoni L, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 2001;31:495-9. (Pubitemid 33039764)
18. Murakami S, Sakata H, Tsuji Y, Okubo K, Hamada S, Hirayama R. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer. Dig Surg 2002;19:9-13. (Pubitemid 34310050)
19. Forones NM, Mandowsky SV, Lourenço LG. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology 2001;48:1199-201. (Pubitemid 32757776)
20. Maeta M, Saito H, Katano K, Kondo A, Tsujitani S, Makino M, et al. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer. Int J Mol Med 1998;1:113-6.